Nat Simons Baxter International Inc Transaction History

Meritage Group LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$74.57 - $87.19 $193,434 - $226,170	-2,594 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$73.77 - $83.61 $191,359 - $216,884	2,594 New	2,594 $209,000
Q1 2021 May 14, 2021	SELL	$76.38 - $86.03 $201,414 - $226,861	-2,637 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$75.39 - $82.36 $81,044 - $88,537	-1,075 Reduced 28.96%	2,637 $212,000
Q3 2020 Nov 13, 2020	BUY	$78.33 - $90.73 $290,760 - $336,789	3,712 New	3,712 $299,000

981

446M

2.22M

3.04M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $19.5B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Meritage Group LP, based on Form 13F filings with the SEC.

Stay updated on Meritage Group LP and Nat Simons with notifications on news.